RxDoctor Payments DataLook up a doctor →

Joseph Abboud, MD

Orthopaedic Surgery · Philadelphia, PANPI 1588608731

Payments from drug & device makers

$4,136,104in general payments, 2019–2025

Across 1,240 payments — averaging $3335.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Encore Medical, LP$2.2M
  • Zimmer Biomet$1.3M
  • Restor3d, Inc.$293K
  • Stryker$169K
  • Integra Lifesciences Corporation$59K
  • Globus Medical$32K
  • plus $94K from 32 others
$2,646in research payments, 2019–2025

Across 1 payment — averaging $2646.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Encore Medical, LP$3K

What the payments were for

  • Royalty or licence$1,652,47542%
  • Consulting fees$1,945,55750%
  • Speaking & faculty fees$3,0290%
  • Travel & lodging$64,4132%
  • Food & beverage$21,6291%
  • Education$225,4816%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,136,104 in reported general payments places this provider in the 95th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.

See all orthopaedic surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$194,000
Medicare patients
336
Services billed
1,564

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl37$133
Tramadol Hcl13$43

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →